section name header

Y-Site Injection Compatibility (1:1 Mixture)

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

I

Aztreonam

(Mfr: BMS)(Conc: 20 mg/mLa)

Remarks:

Precipitate forms immediately

Ref:

2928